Kura Oncology Inc (KURA)
Kura Oncology stock today
Kura Oncology closed at $10.26 on October 30, 2026, down 2.84% on the day. Over the past year it returned -1.7% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $911 million.
| Period | KURA | S&P 500 (SPY) |
|---|---|---|
| 1 month | -4.2% | -0.9% |
| 3 months | +10.2% | +2.1% |
| Year to date | -1.3% | +11.7% |
| 1 year | -1.7% | +12.4% |
| 3 years | +25.9% | +88.5% |
| 5 years | -37.5% | +76.0% |
Key statistics
- Market value
- $911M
- Price / sales
- 11.8
- 52-week range
- $7.40 to $13.59
- Next report
- Nov 3, 2026
About Kura Oncology
Develops oncology therapeutics targeting cancer cell proliferation and survival pathways.
Sector: Health Care
More on Kura Oncology
- Returns: what $1,000 became$1,000 ten years ago is $2,359 today
No forecast, no recommendation. This page describes Kura Oncology Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.